The Business of Alt Protein: Bringing Cultivated Meat to Market in the United States
Event description
In late 2022, the cultivated meat industry hit an important milestone – UPSIDE Foods became the first cultivated meat company to successfully complete the U.S. Food & Drug Administration (FDA)’s pre-market consultation. The FDA has also shared in a recent update that it is currently in pre-market consultation discussions with other cultivated meat companies.
As we come closer to full regulatory approval, join GFI experts to review the current status of the cultivated meat industry and to take a deep dive into the recent advancements that have taken place in the United States. In this webinar we will cover:
- Overview of the cultivated meat production process
- The US regulatory pathway
- Consumer messaging and nomenclature
- Audience Q&A with GFI scientific, regulatory, and market experts
Meet the speakers
Our speakers today include experts from GFI’s corporate engagement, science and technology, and policy teams. We will be joined by:
- Faraz Harsini, Senior Scientist, Bioprocessing
- Laura Braden, Lead Regulatory Counsel
- Madeline Cohen, Regulatory Attorney
- Emma Ignaszewski, Associate Director, Industry Intelligence & Initiatives
Upcoming events
View all events
The Business of Alt Protein: What founders need to know about M&A for mission-driven companies
Join GFI for a Business of Alt Protein webinar featuring a presentation from Tuck Advisors on mergers and acquisitions for mission driven companies.
The Science of Alt Protein: Nature and nurture—Cell lines and media
Discover opportunities for the convergent development of both cell lines and media for cultivated meat.
